Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Supplemental Filings: FDA Can't 'Plug' All Shortage Holes, New Jobs For Billy Dunn, Lisa Parks & Heidi Rebello

May 23 2023

• By Pink Sheet Team

supplemental filings

Related Content

Transparency Looms Large In US FDA’s Next-Pandemic Legislative Agenda

Mar 15 2023

Medicare Price Inflation Rebates Levied On 27 Part B Drugs In First Round; Pfizer Tops The List

Mar 15 2023

CDER Laments Lack Of Shortage Funding, But FDA Didn’t Request New Money For 2024

Apr 17 2023

HHS Officials Raise Concerns About Pricing, Patent Restrictions for Medical Countermeasures

May 05 2023

US FDA Neuroscience Office Director Billy Dunn Departs As Agency Faces New Review Challenges

Feb 27 2023

Related Companies

Prothena Corporation plc

Sarepta Therapeutics, Inc.

Amylyx Pharmaceuticals, Inc.

Biogen, Inc.

Additional Topics

United States FDA Leadership Regulation Generic Drugs Supply Chain BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window